1. Introduction {#sec0005}
===============

Venous malformations of the bone of the maxillofacial region are rare. They account for less than 1% of all bony "tumors" [@bib0005; @bib0010; @bib0015] and are most frequently described in the vertebral column and calvarium [@bib0010]. The maxilla and mandible are the most commonly affected bones of the facial skeleton [@bib0015], followed by the zygoma, the orbit, and the condyle [@bib0010]. Fifty two cases of venous malformation (VM) of the zygoma have been reported in the literature [@bib0060; @bib0015]. Intraosseous venous malformation (IOVM) presents a rare yet unique clinical challenge to the surgeon. The keys for treatment are: (1) hemorrhage control, (2) en-bloc resection of the bony lesion including the normal bone, and (3) reconstruction after resection. Because of significant hemorrhage risk, intraosseous vascular anomalies can be life-threatening entities. Twenty five deaths by spontaneous hemorrhage have been reported in the literature [@bib0005]. In these literature, even the small lesions of VM may have significant hemorrhage risk. We present here a case of IOVM of the zygoma. Preoperative angiography was performed to confirm the diagnosis followed by embolization to reduce the risk of bleeding during the operation. A good cosmetic result was achieved using autologous calvarial bone for reconstruction of the zygoma defect.

2. Presentation of a case {#sec0010}
=========================

A 59-year-old female presented with a 3-month history of progressive painless swelling of the left cheek. A hard, immobile mass of the malar eminence was palpable ([Fig. 1](#fig0005){ref-type="fig"}A). Computed tomography (CT) showed a round, well-defined expansile bony lesion measuring 5 cm in the left zygoma. The honeycomb lesion was also evident on 3-dimensional CT (3DCT) ([Fig. 1](#fig0005){ref-type="fig"}B). Posteriorly, the lesion tapered into the anterior zygomatic arch. There were neither periosteal lesions nor any associated soft tissue lesions. The mass had an overall intermediate T1 signal intensity and a high T2 signal intensity on magnetic resonance imaging (MRI). Within the mass were areas of no signal that corresponded to the trabeculae seen on the CT study. No extra-osseous soft tissue component was apparent. On biopsy, significant hemorrhage was caused. The pathology revealed the lesion to be a cavernous hemangioma.

Preoperative superselective angiography and embolization were performed. Selective bilateral external carotid artery angiograms displayed markedly hypertrophied branches of the left facial artery and left internal maxillary artery ([Fig. 2](#fig0010){ref-type="fig"}A). After microcatheter embolization, en-bloc resection of the zygoma including the VM was performed with a subcilial and intraoral approach to avoid postoperative facial nerve palsy caused by preauricular approach. The total blood loss was approximately 500 ml. Anatomical reconstruction of the zygoma and orbital floor was performed by using a 5 × 5 cm split parietal calvarial bone for the zygoma and a split iliac bone for the orbital floor. The split calvarial bone was taken primarily using a surgical chisel. The resulting calvarial bone donor site was repaired using hydroxyapatite bone cement.

Histology of the affected area (hematoxylin and eosin staining) revealed thin-walled, enlarged vascular channels with a single layer of flat, quiescent endothelium between bony trabeculae. The endothelium showed no signs of proliferation, mitotic figures, atypia, or tufting, and the bony margins did not show any sign of vascular anomaly.

Follow-up at 6 months demonstrated no significant deformity of the left zygoma, with good contour of the midface on clinical examination ([Fig. 2](#fig0010){ref-type="fig"}B). CT scan at 6 month　postoperatively, revealed volume maintenance and anatomical continuity of the calvarial bone grafts ([Fig. 3](#fig0015){ref-type="fig"}). After over 3 years, the patient appears no recurrence or deformity of the left zygoma.

3. Discussion {#sec0015}
=============

A literature review of IOVM of the zygoma is shown in [Table 1](#tbl0005){ref-type="table"}. Hemangiomas (Hs) and cavernous hemangiomas (CHs) are included types of IOVM. The incidence of intraosseous venous malformations of the zygoma occurs in a female to male ratio of 4.5:1. In 7% of cases, preoperative arterial embolization followed by total resection of the lesion was performed. With regard to reconstruction, 40% were with autologous calvarial bone graft and 40% were with non-autologous substances, such as silicone [@bib0015], polyethylene [@bib0015; @bib0030], titanium plate [@bib0015; @bib0035], orhydroxyapatite paste [@bib0020; @bib0025]. There was one recurrence after 6 months, and infection was reported in two cases that were reconstructed with hydroxyapatite [@bib0045].

3.1. Classification {#sec0020}
-------------------

Historically, the reporting of vascular anomalies has been misrepresented in the literature through the indiscriminate use of the term "hemangioma" to describe a variety of distinct vascular lesions [@bib0015; @bib0050; @bib0060]. This ambiguity has led to misconceptions and inaccuracies regarding the appropriate diagnostic approach and therapeutic management of vascular lesions [@bib0005; @bib0060].

The International Society for the Study of Vascular Anomaly (ISSVA) classification is a reasonable classification that leads to appropriate clinical diagnosis and treatment strategies with the differentiation of vascular tumors and VM using simple, easily comprehensible nomenclature [@bib0050; @bib0060]. Although VMs have been described differently in the WHO classification as well as in the prominent textbook of Enzinger ans Weiss, the ISSVA classification is the most logical and clear classification system [@bib0050]. Prior nomenclatures including cavernous hemangioma, venous hemangioma, intramuscular hemangioma, and synovial hemangioma are all categorized as VM in the ISSVA classification [@bib0050].

3.2. Etiology {#sec0025}
-------------

VMs are malformations of the vascular system present at birth [@bib0005]. The frontal bone is the most common site (31%) followed by the temporal (13%) and zygomatic bones (12%) [@bib0055]. VMs are approximately 3--5 times more common in females than males [@bib0010; @bib0015; @bib0055].

3.3. Diagnosis {#sec0030}
--------------

Zygomatic IOVMs may cause deformity of the cheek and orbit with proptosis and diplopia. Focal neurological findings and bruits are uncommon until late in their course [@bib0005].

The CT appearance most commonly shows a characteristic sharply marginated expansile lesion with intact inner and outer tables and a sunburst pattern of radiating trabeculae. "Soap bubble" and "honeycomb" configurations may also occur [@bib0010; @bib0060]. In the MRI, VM shows low to iso-intense areas within the muscle on T1 imaging with high intensity areas on T2 imaging [@bib0010]. In our case, the diagnosis of IOVM of the zygoma was suggested on the basis of the morphologic similarity of the lesion to a calvarial hemangioma. Intraoperatively, the lesions looked to be hard, blue--violet domed masses lying beneath the periosteum, and the bone seemed spongy.

Angiography is essential not only to confirm the diagnosis, but also to aid in the preoperative management of the tumors [@bib0065]. VMs often show dilations of the vascular supply and venous drainage, pooling of contrast in ectatic vascular spaces, and shunting. Because multiple arteries supply the lesion, embolization needs to be performed before the operation to prevent hemorrhage [@bib0065; @bib0070].

3.4. Treatment {#sec0035}
--------------

Total en-bloc excision of bony lesions followed by reconstruction may be curative [@bib0015; @bib0020; @bib0060]. The indications for treatment include mass effect, high risk of hemorrhage, and cosmesis. Different types of treatments have been described including radiotherapy, embolization of the main afferent vessels, curettage, and resection [@bib0060; @bib0075]. Radiotherapy may stop the progress of the lesion but does not address the cosmetic deformity and has the risks of tissue necrosis, retardation of growth of bones and teeth, telangiectasias, and malignant degeneration [@bib0015; @bib0045]. Although embolization or ligation of the external carotid artery has been described, this strategy not only can lead to incomplete remission of the lesions, but also carries with it a risk of recurrence. En-bloc resection including a margin of normal bone around the lesion can decrease the recurrence and simultaneously avoid disastrous bleeding [@bib0005; @bib0030; @bib0035; @bib0045]. The honeycomb appearance of these lesions on CT is the result of reactive osteoblastic bone remodeling in response to the stress created by the enlarging VM, and the lesions are continuous with the normal surrounding bone. It is important to distinguish the margins of lesion in order to resect normal bone around it. The postoperative complications may be partial infection, disformity and recurrence. Temporary facial palsy has not found in among the literature regarding with IOVM of zygoma.

3.5. Reconstruction {#sec0040}
-------------------

The zygoma is critical to facial aesthetics. Reconstruction after resection is of great importance to preserve aesthetics and for ocular functionality of the zygoma orbital region. Primary reconstruction can maintain a normal bony foundation and prevent soft-tissue contraction [@bib0035; @bib0045]. Various reconstructive methods have been used including repair with a surgical pack [@bib0010; @bib0015], silicone implants [@bib0015], titanium mesh implants [@bib0015; @bib0035] hydroxyapatite cement [@bib0020; @bib0025], and autologous graft with rib and iliac bone [@bib0015; @bib0030; @bib0080]. We chose autologous parietal calvarial bone over other autologous bone grafts for primary reconstruction because the parietal curve has a similar contour to the zygomatic bone and also calvarial free bone grafts are well preserved in the recipient site, particularly in the face. Experimental studies have demonstrated enhanced volume maintenance for calvarial bone as compared with other traditional bone graft sources [@bib0045; @bib0085; @bib0090]. Because the ratio of cortical bone is higher in calvarial bone than in other bone grafts, such as iliac and rib bones [@bib0085; @bib0090] and its dense cortical nature limits revascularization, the calvarial bone resorption rate is low [@bib0090]. Jinz [@bib0045] described that the use of autologous bone graft is better than using non-autologous materials like methylmethacrylate-based decalcified allograft bone　or bone substitutes like hydroxyapatite cement because these can become infected or resorbed, particularly in the case of hydroxyapatite cement [@bib0045; @bib0085].

4. Conclusions {#sec0045}
==============

The field of vascular malformations has long been hampered by non-uniformity of language, which has frustrated attempts at research, diagnosis, and treatment. Recent advances in research reveal the underlying genesis of these lesions and have led to a coherent, reliable ISSVA classification system that facilitates uniformity in communication and efficacy of treatment. No single medical specialty in isolation can deliver high-quality care to these patients. Collaboration and mutual co-operation between surgeons, radiologists, and pathologists are necessary for accurate diagnosis and management. Superselective arteriography and embolization are extremely important diagnostic and therapeutic tool in arteriovenous and venous forms. The combination of surgery and embolization makes it possible to achieve definitive results. For primary reconstruction of the zygoma, the use of autologous calvarial bone can maintain the volume and reconstruct the natural malar contour via a relatively simple technique.
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![(A) Preoperative view. (B) 3DCT scan image shows a honeycomb lesion in the left zygoma.\
The lesion is a mass of mixed density over the malar eminence of the zygomatic bone involving the lateral orbital wall on the left side.](gr1){#fig0005}

![(A) Lateral view of the selective left internal maxillary arteriogram before embolization. Homogenous staining was seen in the circle. The left internal maxillary artery was feeding the lesion. (B) Patient at 6 months postoperative.](gr2){#fig0010}

![3DCT scan imaging 6 months postoperatively.](gr3){#fig0015}

###### 

Literature review of intraosseous venous malformations of the zygoma.

  Authors                                      Year             Age/sex          Diagnosis                Treatment                                     Reconstruction
  -------------------------------------------- ---------------- ---------------- ------------------------ --------------------------------------------- ----------------------------------
  Schoefield[@bib0015]                         1950             18 Month/male    H                        Excision                                      NP
  Sherman and Wilner[@bib0015]                 1950             46 Year/female   H                        Excision                                      NP
  Walker and McHenry[@bib0015]                 1950             40 Year/female   Capillary H              Excision                                      NR
  1950                                         10 Year/female   H                Excision                 NR                                            
  Davis and Morgan[@bib0015]                   1950             47 Year/female   CH                       Ligation of exernalcarotid A. and excision    Rib bone graft
  Marshack[@bib0015]                           1950             53 Year/female   Capillary H              Excision                                      Pedicled fatty tissue
  1950                                         35 Year/female   Capillary H      Excision and curettage   Layer of surgical                             
  Schmidt[@bib0015]                            1950             43 Year/female   Capillary H              Excision and curettage                        Pedicled fatty tissue
  Har-EL and Hadar[@bib0015]                   1950             60 Year/male     CH                       Excision                                      Silicone
  1950                                         43 Year/female   Mixed CH         Excision                 Silicone layer                                
  1950                                         58 Year/male     CH               Excision                 Silicone layer                                
  Warman and Myssiorek[@bib0015]               1950             38 Year/female   CH                       TR                                            Iliac bone
  Jeter and Hockney[@bib0015]                  1950             1 Month/female   CH                       Ligation of exernalcarotid A. and curettage   Surgical removed postoperatively
  50 Year/female                               CH               Excision         Iliac bone graft                                                       
  Clauser and Meneghini[@bib0015]              1991             56 Year/female   CH                       TR                                            Split calv. bone
  35 Year/female                               CH               TR               Split calv. bone                                                       
  Cuesta Gil and Navarro-Vila[@bib0015]        1992             12 Year/female   CH                       AE + TR                                       Split calv. bone
  Savastano, Russo, and Aquila[@bib0015]       1997             41 Year/female   H                        TR                                            Calv. flap
  Hirano[@bib0020]                             1997             83 Year/female   CH                       TR                                            Hydroxyapatite
  Yoshioka                                     2001             72 Year/female   CH                       TR                                            Titunium mesh
  Konior and Kelly[@bib0015]                   1999             45 Year/female   MH                       TR                                            Calv. bone
  Moore and Chun[@bib0015]                     2001             31 Year/female   H                        AE + TR                                       Titan plate
  Colombo et al.[@bib0015]                     2001             75 Year/male     CH                       TR                                            NS
  Nakatani[@bib0080]                           2003             9 Year/female    CH                       TR                                            Rib bone graft
  Koybasi, Saydam and Kutlay[@bib0025]         2003             33 Year/female   CH                       TR                                            Hydroxyapatite
  Fernandez, Luberti and Dominguez[@bib0015]   2003             26 Year/female   NS                       TR or SR                                      NS
  Ramchdani and Sabesan[@bib0015]              2004             38 Year/female   CH                       TR                                            Pedicled calv. flap
  Perugini, Renzi, and Beceli[@bib0015]        2004             60 Year/male     MH                       TR                                            Calv. bone
  43 Year/male                                 Cellular H       TR               Calv. bone                                                             
  32 Year/male                                 MH               TR               Calv. bone                                                             
  46 Year/female                               Cellular H       TR               Medpor                                                                 
  32 Year/female                               MH               TR               Medpor                                                                 
  38 Year/female                               Cellular H       TR               NR                                                                     
  Cheng et al.[@bib0095]                       2006             50 Year/female   CH                       PR/later TR                                   NP
  Zins, Turegun, and Hosn[@bib0045]            2006             36 Year/female   CH                       TR                                            Calv. bone P.O. 6 m
  Riveros et al.[@bib0015]                     2006             72 Year/NS       NS                       TR                                            NP
  Sakamoto et al.[@bib0040]                    2007             47 Year/female   CH                       TR                                            Ceratite
  Gomez et al.[@bib0015]                       2008             35 Year/female   IOH                      TR                                            Calv. bone
  Valentino et al.[@bib0030]                   2008             57 Year/male     IOH                      TR                                            Rib bone graft
  NS/NS                                        IOH              TR               Medpor/removal                                                         
  NS/NS                                        IOH              TR               Medpor/removal                                                         
  NS/NS                                        IOH              TR               Medpor                                                                 
  NS/NS                                        IOH              TR               Calv. bone                                                             
  NS/NS                                        IOH              TR               Calv. bone                                                             
  Srinivasan et al.[@bib0060]                  2009             66 Year/female   VM                       TR                                            NP
  Zinz^17^                                     2010             NS/NS            IOH                      TR                                            Calv. bone
  Defazio et al.[@bib0015]                     2011             52 Year/female   VM                       Surveillance                                  NP
  50 Year/female                               VM               TR               Calv. bone                                                             
  49 Year/male                                 VM               TR               Harvested bone                                                         
  Dhupar and Yadav[@bib0075]                   2012             34 Year/female   CH                       TR                                            NP
  Leiboritch et al.[@bib0100]                  2012             47 Year/female   IOCH                     TR                                            NP
  This case                                    2013             59 Year/female   IOVM                     AE + TR                                       Calv. bone

H -- hemangioma; CH -- cavernous hemangioma; MH -- mixed hemangioma; IOH -- intraosseous hemangioma; TR -- total resection; PR -- partial resection; NP -- not performed; and NS -- not stated.
